25H-NBOMe (NBOMe-2C-H) is a derivative of the
phenethylamine hallucinogen
Hallucinogens are a large, diverse class of psychoactive drugs that can produce altered states of consciousness characterized by major alterations in thought, mood, and perception as well as other changes. Most hallucinogens can be categorize ...
2C-H
2C-H (2,5-dimethoxyphenethylamine) is a lesser-known substituted phenethylamine of the 2C family.
History
2C-H was first synthesized in 1932 by Johannes S. Buck.
Use
2C-H is used as a precursor in the synthesis of other substituted phenethyla ...
, which acts as a highly
potent partial agonist
In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist. They may also be considered ligands which display both agonistic and antagonis ...
for the
human
Humans (''Homo sapiens'') are the most abundant and widespread species of primate, characterized by bipedalism and exceptional cognitive skills due to a large and complex brain. This has enabled the development of advanced tools, cultu ...
5-HT2A receptor
Receptor may refer to:
* Sensory receptor, in physiology, any structure which, on receiving environmental stimuli, produces an informative nerve impulse
*Receptor (biochemistry), in biochemistry, a protein molecule that receives and responds to a ...
.
Legality
Sweden
The Riksdag added 25H-NBOMe to
Narcotic Drugs Punishments Act under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of August 1, 2013, published by
Medical Products Agency (MPA) in regulation ''LVFS 2013:15'' listed as 25H-NBOMe, and 2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin.
United Kingdom
See also
*
2CBCB-NBOMe
2CBCB-NBOMe (NBOMe-TCB-2) is a compound indirectly derived from the phenethylamine series of hallucinogens, which was discovered in 2007 at Purdue University as part of the ongoing research program of the team led by David Nichols focusing on t ...
(NBOMe-TCB-2)
*
2CBFly-NBOMe
2CBFly-NBOMe (NBOMe-2C-B-FLY, Cimbi-31) is a compound indirectly derived from the phenethylamine hallucinogen 2C-B, and related to benzodifurans like 2C-B-FLY and ''N''-benzylphenethylamines like 25I-NBOMe. It was discovered in 2002, and further ...
(NBOMe-2CB-Fly)
*
2C-C-NBOMe
25C-NBOMe (NBOMe-2C-C, 2C-C-NBOMe, Cimbi-82) is a psychedelic drug and derivative of the psychedelic phenethylamine 2C-C. 25C-NBOMe appeared on online vendor sites in 2010 but was not reported in the literature until 2011.
It acts as a potent ag ...
(NBOMe-2CC)
*
25B-NBOMe (NBOMe-2CB)
*
25I-NBOMe (NBOMe-2CI)
*
25I-NBMD
25I-NBMD (NBMD-2C-I, Cimbi-29) is a derivative of the phenethylamine hallucinogen 2C-I, discovered in 2006 by a team at Purdue University led by David Nichols. It acts as a potent partial agonist for the 5HT2A receptor
Receptor may refer to:
...
(NBMD-2CI)
*
25B-NBOH
*
25I-NBOH (NBOH-2CI)
References
{{Phenethylamines
25-NB (psychedelics)
Designer drugs